Woman Regrows Hair After Severe Alopecia With New Treatment

Jessica pulled her hair into a messy bun during college when her mom spotted something alarming: three round bald spots on the back of her head.

The 35-year-old wasn't completely surprised. Her dad had alopecia areata, an autoimmune disease where the body mistakenly attacks hair follicles, causing hair loss.

She figured she'd have years before serious hair loss kicked in, just like her dad did. But within 14 months, all the hair on her head was gone.

Jessica's dermatologist tried topical medications and steroid injections, but nothing stopped the progression. She turned to wearing a wig daily, which came with its own challenges.

The wigs got uncomfortably hot during exercise and warm weather. She couldn't swim or ride roller coasters anymore without worrying about her wig.

Dating became complicated too. Jessica struggled with when to tell dates about her hair loss, not too soon, but not too late either.

Then Jessica discovered something new while connecting with others online. She learned about LITFULO, a once-daily prescription pill the FDA approved in 2023 for severe alopecia areata in adults and teens 12 and up.

At her next dermatologist appointment, Jessica asked three key questions: Would it work for her? What were the side effects? What would treatment look like?

Her doctor explained that LITFULO works inside the body to block the immune system's attack on hair follicles. They discussed the potential risks, including serious infections, increased risk of death, cancer, immune system problems, major cardiovascular events, blood clots, and allergic reactions.

After honest conversations and required screening, Jessica started LITFULO in January 2024. She didn't know what to expect but felt excited about trying something new.

Within a few months, Jessica noticed promising regrowth starting on top of her head. Month after month, her hair got longer and more filled in.

In clinical studies, close to 25 percent of people taking LITFULO saw 80 percent or more scalp hair coverage after six months, compared to 1.6 percent on placebo. Jessica took monthly progress pictures to track her growth.

Common side effects in clinical trials included headache, diarrhea, acne, rash, hives, folliculitis, fever, eczema, dizziness, shingles, decreased red blood cell counts, and mouth sores.

Why This Inspires

Jessica's story represents more than just hair regrowth. It shows how medical innovation is giving people with autoimmune conditions new options when traditional treatments don't work.

Around one year into treatment, Jessica debuted her new hair and stopped wearing wigs. She can finally see the person she's used to seeing when she looks in the mirror.

For people living with alopecia areata, advances like LITFULO offer something that felt impossible before: hope that regrowth is possible.